Simultaneously, BD impairs insulin signaling via acetaldehyde and ROS, which inhibit the phosphorylation of insulin receptor substrate-1 (IRS-1) and reduce glucose transport efficiency (27, 28). The gene discussed is IRS1; the disease is Behcet disease.